Skip To Main Content
Kindstar Biotech Wuhan on Muck Rack

Kindstar Biotech Wuhan

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kindstar Biotech

Contact Kindstar Biotech, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Risk Stratification for Diffuse Large B‐Cell Lymphoma by Integrating Interim 18F‐FDG PET‐CT Analysis and the NCCN‐IPI: A Multicenter Retrospective Study

|
By Yong Sun, Jiesong Wang, Kindstar Biotech Wuhan, Meifu Lin
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Supporting Information Filename Description hon70118-sup-0001-suppl-data.docx3.1 MB Supporting Information S1 References 1 and , “New Approach to Classifying Non-Hodgkin’s Lymphomas: Clinical Features of the Major Histologic Subtypes. Non-hodgkin’s Lymphoma Classification Project,” Journal of Clinical Oncology 16, no. 8 (1998): 2780–2795, https://doi.org/10.1200/jco.1998.16.8.2780. 2, , , et al.
Open in Who Shared Issue with article?
See all 1 articles